Abstract
Melatonin (N-acetyl-5-methoxytryptamine), an endogenously produced indole found throughout the animal kingdom, was recently reported, using a variety of techniques, to be a scavenger of a number of reactive oxygen and reactive nitrogen species both in vitro and in vivo. Initially, melation was discovered to directly scavenge the high toxic hydroxyl radical (•OH). The methods used to prove the interaction of melatonin with the •OH included the generation of the radical using Fenton reagents or the ultraviolet photolysis of hydrogen peroxide (H2O2) with the use of spin-trapping agents, followed by electron spin resonance (ESR) spectroscopy, pulse radiolysis followed by ESR, and several spectrofluorometric and chemical (salicylate trapping in vivo) methodologies. One product of the reaction of melatonin with the •OH was identified as cyclic 3-hydroxymelatonin (3-OHM) using high-performance liquid chromatography with electrochemical (HPLC-EC) detection, electron ionization mass spectrometry (EIMS), proton nuclear magnetic resonance (1H NMR) and COSY 1H NMR. Cyclic 3-OHM appears in the urine of humans and other mammals and in rat urine its concentration increases when melatonin is given exogenously or after an imposed oxidative stress (exposure to ionizing radiation). Urinary cyclic 3-OHM levels are believed to be a biomarker (footprint molecule) of in vivo •OH production and its scavenging by melatonin. Although the data are less complete, besides the •OH, melatonin in cell-free systems has been shown to directly scavenge H2O2, singlet oxygen (1O2) and nitric oxide (NO•), with little or no ability to scavenge the superoxide anion radical (O2 •−). In vitro, melatonin also directly detoxifies the peroxynitrite anion (ONOO−) and/or peroxynitrous acid (ONOOH), or the activated from of this molecule, ONOOH*; the product of the latter interaction is proposed to be 6-OHM. How these in vitro findings relate to the in vivo antioxidant actions of melatonin remains to be established. The ability of melatonin to scavenge the lipid peroxyl radical (LOO•) is debated. The weight of the evidence is that melatonin is probably not a classic chain-breaking antioxidant, since its ability to scavenge the LOO• seems weak. Its ability to reduce lipid peroxidation may stem from its function as a preventive antioxidant (scavenging initiating radicals), or yet unidentified actions. In sum, in vitro melatonin acts as a direct free radical scavenger with the ability to detoxify both reactive oxygen and reactive nitrogen species; in vivo, it is an effective pharmacological agent in reducing oxidative damage under conditions in which excessive free radical generation is believed to be involved.
Similar content being viewed by others
References
Halliwell, B. (1994) Free radicals and antioxidants: a personal view. Nutr. Rev. 52, 253–265.
Kehrer, J. P. (1993) Free radicals, mediators of tissue injury and disease, Crit. Rev. Toxicol. 23, 21–48.
McCord, J. M. (1998) The importance of oxidant-antioxidant balance, in Oxidative Stress, Cancer, AIDS and Neurogenerative Diseases (Montagnier, L., Oliver, R., and Pasqier C., eds.), Marcel Dekker, New York, pp. 1–7.
Felton, G. W. (1995) Oxidative stress of vertebrates and invertebrates, in Oxidative Stress and Antioxidative Defenses in Biology (Ahmad, S., ed.), Chapman and Hall, New York, pp. 357–434.
Chance, B., Sies, H., and Boveris, A. (1979) Hydroperoxide metabolism in mammalian tissues. Physiol. Rev. 59, 527–605.
Chaudiére, J. (1994) Some chemical and biochemical constraints of oxidative stress in living cells, in Free Radical Damage and Its Control (Rice-Evans, C. and Burdon, R. H., eds.), Elsevier, Amsterdam, pp. 25–66.
Niki, E., Oikawa, M., and Takahashi, M. (1996) Oxidative cell damage induced by radicals inhibited by antioxidants, in Free Radicals in Brain Physiology and Disorders (Packer, L., Haramatsu, M., and Yoshikawa, T., eds.), Academic, San Diego, pp. 35–44.
Pryor, W. A. (1986) Oxidants and antioxidants in the lung. Annu. Rev. Physiol. 48, 657–663.
Moncada, S., Palmer, R. M. J., and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109–141.
Synder, S. H., and Bredt, D. S. (1992) Biological roles of nitric oxide. Sci. Am. May, 68–77.
Rubbo, H., Radi, R., Trujillo, M., Telleri, R., Kalynaraman, B., Barnes, S., Kirk, M., and Freeman, B. A. (1995) Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J. Biol. Chem. 269, 26,067–26,075.
Rubbo, H., Darley-Usmar, V., and Freeman, B. A. (1996) Nitrite oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9, 809–820.
Moncada, S., and Higgs, A. (1993) The L-arginine-nitric oxide pathway. New Engl. J. Med. 329, 2002–2011.
Radi, R. (1996) Reactions of nitric oxide with metalloproteins. Chem. Res. Toxicol. 9, 828–835.
Brune, D., Dimmeler, S., Moline, V., and Lapetina, E. G. (1994) Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci. 54, 61–70.
Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespura, R. K., Misra, M. K., Runams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., and Allen, T. S. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science 254, 1001–1003.
Crow, J. P., and Beckman, J. S. (1993) Reaction between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv. Pharmacol. 34, 17–43.
Radi, R., Beckman, J. S., Buch, K. M., and Freeman, B. A. (1991) Peroxynitrite oxidation of sulfhydryls. J. Biol. Chem. 266, 4244–4250.
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications of endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620–1624.
Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxynitrite-induced membrane lypid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481–487.
de Zwart, L. L., Meerman, J. H. W., Commandeur, J. N. M. and Vermeulen, N. P. E. (1999) Biomarkers of free radical damage. Applications in experimental animals and in humans. Free Radical Biol. Med. 26, 202–206.
Pryor, W. A., and Squadrito, G. L. (1995) The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268, L699-L722.
Sies, H. (1993) Strategies of antioxidative defense. Eur. J. Biochem. 215, 213–219.
Sies, H. (Ed.) (1997) Antioxidants in Disease Mechanisms and Therapy, Academic Press, San Diego, pp. 707.
Reiter, R. J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev. 12, 151–180.
Yu, H. S., Yee, R. W., Howes, K. A., and Reiter, R. J. (1990) Diurnal rhythms of immunoreactive melatonin in aqueous humor and serum of male pigmented rabbits. Neurosci Lett. 116, 309–314.
Huether, G. (1993) The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experimentia 49, 665–670.
Abe, M., Itoh, M. T., Mijata, M., Ishikawa S., and Sumi, Y. (1999) Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp. Eye Res. 68, 255–262.
Conti, A., Conconi, S., Hertens, E., Skwarlo-Sonta, K., Markowska, M., and Maestroni, G. J. M. (2000) Melatonin synthesis in mouse and human bone marrow cells. J. Pineal Res., 28, 193–202.
Tan, D. X., Manchester, L. C., Reiter, R. L., Qi, W., Zhang, M., Weintraub, S., Cabrera, J., Sainz, R. M., and Mayo, J. C. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta, 1472, 206–214.
Tan, D. X., Manchester, L. C., Reiter, R. J., Qi, W., Hanes, W. A., and Farley, N. J. (1999) High physiological levels of melatonin in the bile of mammals. Life Sci., 65, 2523–2529.
Skinner, D. C., and Malpaux, B. (1999) High melatonin concentrations in the third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 140, 4399–4405.
Menendez-Pelaez, A., Poeggeler, B., Reiter, R. J., Barlow-Walden, L. R., Pablos, M. I., and Tan, D. X. (1992) Nuclear localization of melatonin in different mammalian tissues: immunocyto-chemical and radioimmunoassay evidence. J. Cell. Biochem. 53, 373–382.
Manev, H., Uz, T., Kharlamov, A., and Joo, J. Y. (1996) Increased brain damage after stroke and excitotoxic seizures in melatonin-deficient rats. FASEB J. 10, 1546–1551.
Kilic, E., Özdemir, Y. G., Bolay, H., Kelestimur, H., and Dalkara, T. (1999) Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J. Cerebr. Blood Flow Metab. 19, 511–516.
Menendez-Pelaez, A., and Reiter, R. J. (1993) Distribution of melatonin in mammlian tissues: the relative importance of nuclear versus cytosolic localization. J. Pineal Res. 15, 59–60.
Finnochiarro, L. M. E., and Glikin, G. C. (1998) Intracellular distribution of melatonin in cultured cell lines. J. Pineal Res. 24, 22–34.
Okatani, Y., Okamoto, K., Hayashi, K., Wakatsuki, A., Tamura, S. and Sagara, Y. (1998) Maternal-fetal transfer of melatonin in pregnant women near term. J. Pineal Res. 25, 129–134.
Walkatsuki, A., Okatani, Y., Izumiya, C., and Ikenoue, N. (1999) Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J. Pineal Res. 26, 147–152.
Pardridge, W. M., and Mietus, L. J. (1980) Transport of albumin bound melatonin through the blood-brain barrier. J. Neurochem. 34, 1761–1763.
Vakkuri, O., Leppäluoto, J., and Kauppila A. (1985) Oral administration and distribution of melatonin in human serum, saliva and urine. Life Sci. 37, 489–495.
Lee, B. J., and Min, G. H. (1996) Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. Int. J. Pharm. 144, 37–46.
Yeleswaran, K., McLaughlin, L. G., Knipe, J. O., and Schabdach, D. (1997) Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J. Pineal Res. 22, 45–51.
Lee, B. J., Parrott, K. A., Ayres, J. W., and Sack, R. L. (1994) Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res. Commun. Mol. Pathol. Pharmacol. 85, 337–344.
Vollrath, L., Semm, P., and Gamal, G. (1998) Sleep induction by intranasal application of melatonin, in Melatonin: Current Status and Perspectives (Birau, W., Schlott, W., eds.) Pergamon, Oxford, pp. 327–329.
Bechgaard, E., Lindhardt, K., and Martinsen, L. (1999) Routes of melatonin administration. Int. J. Pharmaceut. 182, 1–6.
Mallo, C., Zaidan, R., Galy, G., Vermeulen, E., Brun, J., Chazot, G., and Claustrat, B. (1990) Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur. J. Clin. Pharmacol. 38, 297–301.
Neville, S., Arendt, J., and Ioannides, C. (1989) A study of the mutagenicity of melatonin and 6-hydroxymelatonin. J. Pineal Res. 6, 73–76.
Arendt, J. (1997) Safety of melatonin in long term use. J. Biol. CRythms 12, 673–688.
Avery, D., Lenz, M., and Landis, C. (1998) Guidelines for prescribing melatonin. Ann. Med. 30, 122–130.
Geoffriau, M., Brun, J., Chazot, G., and Claustrat, B. (1998) The physiology and pharmacology of melatonin in humans. Horm. Res. 49, 136–141.
Gibb, J. W., Bush, L., and Hanson, G. R. (1997) Exacerbation of methamphetamine-induced neurochemical deficits by melatonin. J. Pharmacol. Exp. Ther. 283, 630–635.
Coggins, C. and Sloan, N. L. (1998) Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 351, 1254–1255.
Yeleswaran, K., Vachharajani, N., and Santone, K. (1999) Involvement of cytochrome P-450 isozymes in melatonin metabolism and clinical implications. J. Pineal Res. 26, 190–191.
Benot, S., Molinero, P., Soutto, M., Goberna, R., and Guerrero, J. M. (1998) Circadian variations in the rat serum total antio xidant status: correlation with melatonin levels. J. Pineal Res. 25, 1–4.
Benot, S., Goberna, R., Reiter, R. J., Garcia-Maurino, S., Osuna, C., and Guerrero, J. M. (1991) Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J. Pineal Res. 27, 59–64.
Reiter, R. J. (1991) Melatonin: the chemical expression of darkness. Mol. Cell. Endocrinol. 79, C153-C158.
Hardeland, R., Balzer, I., Poeggeler, B., Fuhrberg, B., Uria, H., Behrmann, G., Wolf, R., Meyer, T. J., and Reiter, R. J. (1995) On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a uni-cell, photooxidation and scavenging of free radicals. J. Pineal Res. 18, 104–111.
Hardeland, R. (1997) New actions of melatonin and their relevance to biometeorology. Int. J. Biometeorol. 41, 47–57.
Reiter, R. J., Melchiorri, D., Sewerynek, E., Poeggeler, B., Barlow-Walden, L. R., Chuang, S. H., Ortiz, G. G., and Acuña-Castroviejo, D. (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18, 1–11.
Reiter, R. J., Oh, C. S., and Fujimori, O. (1996) Melatonin: its intracellular and genomic actions. Trends Endocrinol. Metab. 7, 22–27.
Poeggeler, B. (1998) Melatonin: radical detoxification by electron donation, in Reactive Oxygen Species in Biological Systems (Gilbert, D. L., and Colton, C. D., eds.), Plenum, New York, pp. 421–451.
Tan, D. X., Chen, L. D., Poeggeler, B., Manchester, L. C., and Reiter, R. J. (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J. 1, 57–60.
Reiter, R. J. (1980) The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev. 1, 109–131.
Reiter, R. J. (1991) Melatonin: that ubiquitously acting pineal hormone. News Physiol. Sci. 6, 223–227.
Finkelstein, E., Rosen, G. M., and Rauckman, E. J. (1980) Spin trapping. Kinetics of the reaction of superoxide and hydroxyl radicals by nitrones. J. Am. Chem. Soc. 102, 4994–4999.
Pritsos, C. A., Constantinides, D. P., Trilton, T. R., Heimbrook, D. C., and Satorelli, A. C. (1985) Use of high-performance liquid chromatography to detect hydroxyl and superoxide radicals generated from mitomycin C. Anal. Biochem. 150, 294–299.
Towell, J. and Kalyanaraman, B. (1991) Detection of radical adducts of 5,5-dimethyl-1-pyrroline N-oxide by the combined use of high performance liquid chromatography and electrochemical detection and electron spin resonance. Anal. Biochem. 196, 111–119.
Poeggeler, B., Saarela, S., Reiter, R. J., Tan, D. X., Chen, L. D., Manchester, L. C., and Barlow-Walden, L. R. (1994) Melatonin—a highly potent endogenous radical scavenger and electron donor: new aspects of oxidation chemistry of this indole assessed in vitro. Ann. N.Y. Acad. Sci. 738, 419–420.
Poeggeler, B., Reiter, R. J., Hardeland, R., Tan, D. X., and Barlow-Walden, L. R. (1996) Melatonin and structurally related endogenous indoles act as potent electron donors and radical scavengers in vitro. Redox Rep. 2, 179–184.
Poeggeler, B., Reiter, R. J., Hardeland, R., Sewerynek, E., Melchiorri, D., and Barlow-Walden, L. R. (1995) Melatonin, a mediator of electron transfer and repair reactions, acts synergistically with the chain-breaking antioxidants ascorbate, trolox and glutathione. Neuroendocrinol. Lett. 17, 87–92.
Matuszek, Z., Reszka, K. J., and Chignell, C. F. (1997) Reaction of melatonin and related indoles with hydroxyl radicals: ESR and spin trapping investigations. Free Radical Biol. Med. 23, 367–372.
Susa, N., Ueno, S., Furukawa, Y., Ueda, J., and Sugiyama, M. (1997) Potent protective effect of melatonin on chromium (VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 144, 377–384.
Brömme, H. J., Ebelt, H., Peschke, D., and Peschke, E. (1999) Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin. Cell. Mol. Life Sci. 55, 487–493.
Stasica, P., Ulanski, P., and Rosiak, J. M. (1998) Melatonin as a hydroxyl radical scavenger. J. Pineal Res. 25: 65–66.
Stasica, P., Ulanski, P., and Rosiak, J. M. (1998) Reaction of melatonin with radicals in deoxy-genated aqueous solutions. J. Radioanal. Nucl. Chem. 232, 107–113.
Roberts, J. E., Hu, D. N., and Wishart, J. F. (1998) Pulse radiolysis studies of melatonin and chloromelatonin. J. Photochem. Photobiol. B:Biol. 42, 125–132.
Mahal, H. S., Sharma, H. S., and Mukherjee, T. (1998) Antioxidant properties of melatonin: a pulse radiolysis study. Free Radical Biol. Med. 26, 557–565.
Pähkla, R., Zilmer, M., Kullisar, T., and Rägo, L. (1998) Comparison of the antioxidant activity of melatonin and pinoline in vitro. J. Pincal Res. 24, 96–101.
Barreto, J. C., Smith, G. S., Strobel, N. H. P., McQuillin, P. A., and Miller, T. A. (1995) Terephthalic acid: a dosimeter for the production of free radicals in vitro. Life Sci. 56, PL89-PL96.
Li, X. J., Zhang, L. M., Gu, J., Zhang, A. Z., and Sun, F. Y. (1997) Melatonin decreases production of hydroxyl radical during ischemia-reperfusion. Acta Pharmacol. Sinica 18, 394–396.
Tan, D. X., Manchester, L. C., Reiter, R. J., Plummer, B. F., Hardies, L. J., Weintraub, S., Vijayalaxmi, and Shepherd, A. M. M. (1998) A novel melatonin metabolite, cyclic 3-hydroxy-melatonin: a biomarker of in vivo hydroxyl radical generation. Biochem. Biophys. Res. Commun. 253, 614–620.
Okada, S., Nakamura, N., and Sasaki, K. (1983) Radioprotection of intracellular genetic material, in Radioprotectors and Anticarcinogens (Nygaard, O. F. and Sinic, M. G., eds.), Academic San Diego, pp. 339–356.
Hardeland, R., Reiter, R. J., Poeggeler, B., and Tan, D. X. (1993) The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci. Biobehav. Rev. 17, 347–357.
Reiter, R. J., Tan, D. X., Poeggeler, B., Chen, L. D., and Menendez-Pelaez, A. (1994) Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann. NY Acad. Sci. 719, 1–12.
Tan, D. X., Manchester, L. C., Reiter, R. J., et al. (2000) Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radical Biol. Med. 29, 1177–1185.
Zang, L. Y., Cosma, G., Gardner, H., and Vallyathan, V. (1998) Scavenging of reactive oxygen species by melatonin. Biochim. Biophys. Acta 1425, 469–477.
McCord, J. M. and Fridovich, J. (1969) Superoxide dismutase. An enzyme function for erythrocuprein (hemocruprein). J. Biol. Chem. 244, 6049–6055.
Marshall, K. A., Reiter, R. J., Poeggeler, B., Aruoma, O. I., and Halliwell, B. (1996) Evaluation of the antioxidant activity of melatonin in vitro. Free Radical Biol. Med. 21, 307–315.
Sies, H. (ed.) (1991), Oxidative Stress: Oxidants and Antioxidants, Academic, New York, pp. 426.
Konofsky, J. R. and Sima, P. D. (1993) Singlet-oxygen generation at gas-liquid interfaces: a significant artifact in the measurement of singlet-oxygen fields from ozone-biomolecular reactions. Photochem. Photobiol. 58, 335–340.
DiMascio, P., Bachara, E. J. H., Medeiros, M. H. G., Brivida, K., and Sies, H. (1994) Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide. FEBS Lett. 355, 287–289.
Wefers, H. (1987) Singlet oxygen in biological systems. Bioelectrochem. Bioenerg. 18, 91–104.
Poeggeler, B., Reiter, R. J., Tan, D. X., Chen, L. D., and Manchester, L. C. (1993) Melatonin, hydroxyl radical mediated oxidative damage, and aging. J. Pineal Res. 14, 151–158.
Cagnoli, C. M., Atabay, C., Kharlamova, E., and Manev, E. (1995) Melatonin protects neurons from singlet oxygen induced apoptosis. J. Pineal Res. 18, 222–226.
Reszka, K. J., Matuszak, Z., Bilski, P., Martinez, L. J., and Chignell, C. F. (1996) Scavenging actions of melatonin. Abstr. 18 th Ann. Mtg BEMS, p. 176.
Zang, L. Y., van Kuijk, F. J., Misra, B. R., and Misha, H. P. (1995) The specificity and product of quenching singlet oxygen by 2,2,6,6-tetramethylpiperidine. Biochem. Mol. Biol. Int. 37, 283–293.
King, M. and Scaiano, J. C. (1998) The excited states of melatonin. Photochem. Photobiol. 65, 538–542.
Weiss, S. J. (1989) New Engl. J. Med. 320, 365–376.
Kettle, A. J. (1996) Neutrophils convert tyrosyl residues in albumin to chlorotyrosine. FEBS Lett. 379, 103–106.
Dellegar, S. M., Murphy, S. A., Baurne, A. E., DiCesare, J. C., and Rurser, G. H. (1999) Identification of the factors affecting the rate of deactivation of hypochlorous acid by melatonin. Biochem. Biophys. Res. Commun. 257, 431–439.
Noda, Y., Mori, A., Liburdy, R., and Packer, L. (1999) Melatonin and its precursors scavenge nitric oxide. J. Pincal Res. 27, 159–163.
Beckman, J. S., Chen, J., Ischiropoulos, H., and Crow, J. P. (1994) Oxidative chemistry of peroxynitrite. Methods Enzymol. 233, 229–240.
Gilad, E., Cuzzocrea, S., Zingarelli, B., Salzman, A. L., and Szabo, C. (1997) Melatonin as a scavenger of peroxynitrite. Life Sci. 60, PL169-PL174.
Cuzzocrea, S., Zingarelli, B., Gilab, E., Hake, P., Salzman, A. L., and Szabo, C. (1997) Protective effect of melatonin in carrageenan-induced models of local inflammation. J. Pineal Res. 23, 106–116.
Cuzzocrea, S., Zingarelli, B., Costantino, G., and Caputi, A. P. (1998) Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25, 24–33.
El-Sokkary, G. H., Reiter, R. J., Cuzzocrea, S., Caputi, A. P., Hassanein, A. M. M., and Tan, D. X. (1999) Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan. Shock 12, 402–408.
Zhang, H., Squadrito, G. L., and Pryor, W. A. (1998) The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem. Biophys. Res. Commun. 251, 83–87.
Zhang, H., Squadrito, G. L., Uppi, R., and Pryor, W. A. (1999) Reaction of peroxynitrite with melatonin: a mechanistic study. Chem. Res. Toxicol. 12, 526–534.
Cheeseman, K. H. (1993) Tissue injury by free radicals. Toxicol. Indust. Health 9, 39–51.
Sies, H. and Stahl, W. (1995) Vitamins C and E,β-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 62(Suppl.), 1315S-1321S.
Reiter, R. J. (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56, 359–384.
Pieri, C., Marra, M., Moroni, F., Recchioni, R., and Marcheselli, F. (1994) Melatonin, a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55, PL271-PL276.
Pieri, C., Moroni, F., Marra, M., and Marcheselli, F., and Recchioni, R. (1995) Melatonin is an efficient antioxidant. E. Arch. Gerontol. Geriatrics 20, 159–165.
Scaiano, J. C. (1995) Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J. Pineal Res. 19, 189–195.
Escames, G., Guerrero, J. M., Reiter, R. J., Garcia, J. J., Muñoz-Hoyos, A., Ortiz, G. G., and Oh, C. S. (1997) Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci. Lett. 230, 147–150.
Livera, M. A., Tesoriere, L., D'Arpa, D., and Morreale, M. (1997) Reaction of melatonin with lipoperoxyl radicals in phospholipid bilayers. Free Radical Biol. Med. 23, 708–711.
Longoni, B., Salgo, M. G., Pryor, W. A., and Marchiafava, P. L. (1998) Effects of melatonin on lipid peroxidation induced by oxygen radicals. Life Sci. 62, 853–859.
Antunes, F., Barclay, L. R. C., Ingold, K. U., King, M., Norris, J. O., Scaiano, J. C., and Xi, F. (1999) On the antioxidant activity of melatonin. Free Radical Biol. Med. 26, 117–128.
Wayner, D. D. M., and Burton, G. W. (1989) Scavenging of peroxyl radicals, in Handbook of Free Radicals and Antioxidants in Biomedicine, Vol. III (Schwartz, G. D., ed.), CRC Press, Boca Raton, pp. 223–232.
Tan, D. X., Poeggeler, B., Reiter, R. J., Chen, L. D., Chen, S., Manchester, L. C., and Barlow-Walden, L. R. (1993) The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole. Cancer Lett. 70, 65–71.
Reiter, R. J., Tang, L., Garcia, J. J., and Muñoz-Hoyos, A. (1997) Pharmacological actions of melatonin in free radical pathophysiology. Life Sci. 60, 2255–2271.
Romero, M. P., Osuna, C., Garcia-Pergañeda, A., Carrillo-Vico, A., and Guerrero, J. M. (1999) The pineal secretory product melatonin reduces hydrogen peroxide-induced DNA damage in U-937 cells. J. Pineal Res. 26, 227–235.
Tesoriere, L., D'Arpa, D., Conti, S., Giaccone, V., Pintoudi, A. M., and Livrea, M. A. (1999) Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity. J. Pineal Res. 27, 95–105.
Reiter, R. J., Carneiro, R. C., and Oh, C. S. (1997) Melatonin in relation to cellular antioxidative defense mechanisms. Horm. Metab. Res. 29, 363–372.
Morishima, I., Okumura, K., Mataui, H., Keneko, S., Mumaguchi, Y., Kawakami, K., Makuno, S., Hayakawa, M., Toki, Y., Ito, T., and Hayakawa, T. (1999) Zinc accumulation in adriamycin-induced cardiomyopathy in rats: effects of melatonin, a cardiovascular protectants. J. Pineal Res. 26, 204–210.
de la Lastra, C. A., Motilva, V., Martin, M. J., Nieto, A., Barranco, M. D., Cabeza, J., and Herrerias, M. (1999) Protective effect of melatonin on endomethacin-induced gastric injury in rats. J. Pineal Res. 26, 101–107.
Garcia, J. J., Reiter, R. J., Ortiz, G. G., Oh, C. S., Tang, L., Yu, B. P., and Escames, G. (1998) Melatonin enhances tamoxifen's ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation. J. Membr. Biol. 162, 59–65.
Reiter, R. J., Tan, D. X., Kim, S. J., Manchester, L. C., Qi, W., Garcia, J. J., Cabrera, J. C., El-Sokkary, G., and Rouvier-Garay, V. (1999) Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech. Aging Rev. 110, 157–173.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reiter, R.J., Tan, Dx., Manchester, L.C. et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 34, 237–256 (2001). https://doi.org/10.1385/CBB:34:2:237
Issue Date:
DOI: https://doi.org/10.1385/CBB:34:2:237